These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 11927703)
1. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Friedlander SF; Aly R; Krafchik B; Blumer J; Honig P; Stewart D; Lucky AW; Gupta AK; Babel DE; Abrams B; Gourmala N; Wraith L; Paul C; Pediatrics; 2002 Apr; 109(4):602-7. PubMed ID: 11927703 [TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks. Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C; Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378 [TBL] [Abstract][Full Text] [Related]
4. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692 [TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. Haroon TS; Hussain I; Aman S; Jahangir M; Kazmi AH; Sami AR; Nagi AH; Alvi KH; Iqbal N; Khan KA; Aziz R Br J Dermatol; 1996 Jul; 135(1):86-8. PubMed ID: 8776365 [TBL] [Abstract][Full Text] [Related]
7. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis. Jahangir M; Hussain I; Ul Hasan M; Haroon TS Br J Dermatol; 1998 Oct; 139(4):672-4. PubMed ID: 9892912 [TBL] [Abstract][Full Text] [Related]
9. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group. Hamm H; Schwinn A; Bräutigam M; Weidinger G Br J Dermatol; 1999 Mar; 140(3):480-2. PubMed ID: 10233270 [TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of terbinafine in children. Gupta AK; Cooper EA; Lynde CW Dermatol Clin; 2003 Jul; 21(3):511-20. PubMed ID: 12956204 [TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566 [TBL] [Abstract][Full Text] [Related]
12. Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis. Kullavanijaya P; Reangchainam S; Ungpakorn R J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):272-3. PubMed ID: 9270519 [No Abstract] [Full Text] [Related]
13. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China. Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791 [TBL] [Abstract][Full Text] [Related]
14. Oral terbinafine in tinea capitis in children. Gruseck E; Splanemann V; Bleck O; Ring J; Abeck D Mycoses; 1996; 39(5-6):237-40. PubMed ID: 8909037 [TBL] [Abstract][Full Text] [Related]
15. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. Krafchik B; Pelletier J J Am Acad Dermatol; 1999 Jul; 41(1):60-3. PubMed ID: 10411412 [TBL] [Abstract][Full Text] [Related]
16. Tinea capitis: an overview with emphasis on management. Gupta AK; Hofstader SL; Adam P; Summerbell RC Pediatr Dermatol; 1999; 16(3):171-89. PubMed ID: 10383772 [TBL] [Abstract][Full Text] [Related]
17. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis. Haroon TS; Hussain I; Mahmood A; Nagi AH; Ahmad I; Zahid M Br J Dermatol; 1992 Feb; 126 Suppl 39():47-50. PubMed ID: 1543673 [TBL] [Abstract][Full Text] [Related]
18. Griseofulvin and terbinafine in the treatment of tinea capitis in children. Rademaker M; Havill S N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918 [TBL] [Abstract][Full Text] [Related]
19. Trichophyton tonsurans tinea capitis and tinea corporis: treatment and follow-up of four affected family members. Ravenscroft J; Goodfield MJ; Evans EG Pediatr Dermatol; 2000; 17(5):407-9. PubMed ID: 11085674 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine. Ungpakorn R; Ayutyanont T; Reangchainam S; Supanya S Clin Exp Dermatol; 2004 May; 29(3):300-3. PubMed ID: 15115516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]